FDA Calls Bay Area Global Blood Therapeutics' Sickle Cell Drug a Breakthrough
The BTD decision for voxelotor was based on clinical data submitted from a trio of studies. Source: BioSpace
The BTD decision for voxelotor was based on clinical data submitted from a trio of studies. Source: BioSpace
Gene therapy treatment is a high risk, high reward venture, but the promises of a therapy developed through these programs could be life-changing for patients. Source: BioSpace
Cellectar Biosciences is closing its manufacturing operations and contracting them out. Source: BioSpace
For multiple perspectives on addressing this challenge, three respected individuals involved with the effort to bridge clinical research and clinical health care share their views. Source: BioSpace
Cantor Fitzgerald & Co. and Mizuho Securities USA LLC are acting as joint book-running managers for the offering. Source: BioSpace
Vivek Ramaswamy's Axovant has egg on its face after it was forced to own up to the fact it misreported mid-stage data on a drug it hoped to take into…
As an emerging leader in the field of ophthalmology, Novaliq is currently pursuing two late-stage clinical trials in the United States. Source: BioSpace
The latest collaborations bring the total number of strategic transactions executed by J&J Innovation to more than 350 since its establishment in 2012. Source: BioSpace
About 200 of the job cuts will be in Massachusetts, the remaining in Connecticut. Source: BioSpace
The transaction was led by Signet Healthcare Partners in addition to Crestline Investors with other investors comprised of Cane Investment Partners and existing Leading Pharma members. Source: BioSpace